Merck & Co., Inc. Unit Held Liable in Australian Vioxx Case
Reuters -- Merck & Co's (MRK.N) one-time blockbuster arthritis drug Vioxx doubled the risk of heart attacks and was not fit for sale, an Australian court said on Friday, in a ruling against the U.S. group's Australian unit.